Real-World Utility of an Amplicon-Based Next-Generation Sequencing Liquid Biopsy for Broad Molecular Profiling in Patients With Advanced Non–Small-Cell Lung Cancer

PURPOSE: To assess the feasibility and utility of circulating tumor DNA (ctDNA) by amplicon-based next-generation sequencing (NGS) analysis in the daily clinical setting in a cohort of patients with advanced non–small-cell lung cancer (NSCLC), as an alternative approach to tissue molecular profiling...

Descripción completa

Detalles Bibliográficos
Autores principales: Remon, Jordi, Lacroix, Ludovic, Jovelet, Cecile, Caramella, Caroline, Howarth, Karen, Plagnol, Vincent, Rosenfeld, Nitzan, Morris, Clive, Mezquita, Laura, Pannet, Chloe, Ngocamus, Maud, Le Pechoux, Cecile, Adam, Julien, Grecea, Alina-Miruna, Planchard, David, Vassal, Gilles, Benitez, Jose Carlos, Gazzah, Anas, Green, Emma, Soria, Jean-Charles, Besse, Benjamin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Clinical Oncology 2019
Materias:
Original Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7446523/
https://www.ncbi.nlm.nih.gov/pubmed/32914037
http://dx.doi.org/10.1200/PO.18.00211

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7446523/
https://www.ncbi.nlm.nih.gov/pubmed/32914037
http://dx.doi.org/10.1200/PO.18.00211

Ejemplares similares